Completed Lungs & Breathing NIHR-supported project Cancer
A Phase IIa/IIb study to examine the efficacy and safety of BI 1839100 administered orally twice daily over a 12-week treatment period in patients with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis with clinically significant cough
About this grant
This summary is based on the grant title only — the full abstract was not available.
No substantive source abstract was published for this research project funded by NIHR.
Researchers
Michael Gibbons (Principal Investigator)
Related Research
Grants with similar aims, by meaning.
A Phase Iia/Iib, randomised, double blind, placebo-controlled, parallel-group dose-finding study to examine the efficacy and safety of BI 1839100 administered orally over a 12-week treatment period in patients with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis with clinically meaningful cough
1490-0004 A Phase IIa/IIb, randomised, double blind, placebo-controlled, parallel-group dose-finding study to examine the efficacy and safety of BI 1839100 administered orally over a 12-week treatment period in patients with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis with clinically meaningful cough
A Phase IIa/IIb, randomised, double blind, placebo-controlled,parallel group dose-finding study to examine the efficacy and safetyof BI 1839100 administered orally twice daily over a 12-weektreatment period in patients with idiopathic pulmonary fibrosi...
A Phase IIa/IIb, randomised, double blind, placebo-controlled,parallel group dose-finding study to examine the efficacy and safetyof BI 1839100 administered orally twice daily over a 12-weektreatment period in patients with idiopathic pulmonary fibrosis orprogressive pulmonary fibrosis with clinically significant cough
A randomised, double-blind, placebo-controlled, dose-finding study evaluating efficacy, safety, and tolerability of different oral doses of BI 1819479 over at least 24 weeks in patients with idiopathis pulmonary fibrosis (IPF)
Original classification
Clinical MycologyPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know